Novartis to Buy Myricx Bio for Up to .5 Billion

Novartis to Buy Myricx Bio for Up to $1.5 Billion



Novartis to Buy Myricx Bio for Up to $1.5 Billion
The deal for the privately held U.K.-based biotechnology firm will help bolster Novartis’s oncology capabilities.

Leave a Reply

Your email address will not be published. Required fields are marked *